Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of different solvents of HES preparations on coagulation and platelet function
2007-002122-30Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hetastarch in hypovolemia and Shock (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Primary: Inhibition of coagulation and platelet function. Started Aug 2007; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemiaShock
Beyond the preview
Go deeper on 2007-002122-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002122-30.